BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21117999)

  • 41. Activation of telomerase by human cytomegalovirus.
    Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
    J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomerase activity and telomere detection during early bovine development.
    Betts DH; King WA
    Dev Genet; 1999; 25(4):397-403. PubMed ID: 10570471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer.
    Eissa S; Swellam M; Ali-Labib R; Mansour A; El-Malt O; Tash FM
    J Urol; 2007 Sep; 178(3 Pt 1):1068-72. PubMed ID: 17644139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo inhibition of telomerase activity from Chinese hamster V79 cells.
    Pandit B; Bhattacharyya NP
    Indian J Biochem Biophys; 2001; 38(1-2):42-7. PubMed ID: 11563329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telomere length and telomerase activity in canine mammary gland tumors.
    Yazawa M; Okuda M; Setoguchi A; Iwabuchi S; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Oct; 62(10):1539-43. PubMed ID: 11592316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of telomerase activity utilizing energy transfer primers: comparison with gel- and ELISA-based detection.
    Uehara H; Nardone G; Nazarenko I; Hohman RJ
    Biotechniques; 1999 Mar; 26(3):552-8. PubMed ID: 10090999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telomeric repeat amplification, without shortening or lengthening of the telomerase products: a method to analyze the processivity of telomerase enzyme.
    Szatmari I; Aradi J
    Nucleic Acids Res; 2001 Jan; 29(2):E3. PubMed ID: 11139633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning of the canine telomerase reverse transcriptase gene and its expression in neoplastic and non-neoplastic cells.
    Yazawa M; Okuda M; Kanaya N; Hong SH; Takahashi T; Ohashi E; Nakagawa T; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2003 Nov; 64(11):1395-400. PubMed ID: 14620776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Premature termination of telomeric extension-PCR for detection of telomerase activity.
    Chen R; Qian J; Wang L; Mao YM
    Biotechniques; 2003 Jul; 35(1):158-62. PubMed ID: 12866416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for elevated telomerase activity in small cell carcinoma of the bladder.
    Selli C; Gelmini S; Scott CA; Crisci A; Giannarini G; Orlando C
    Urology; 2000 Aug; 56(2):331. PubMed ID: 10925114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement in detecting telomerase activity using silica-based resin treatment: An experience of urine in bladder carcinoma.
    Yahata N; Nagao K; Ohyashiki JH; Hisatomi H; Ohyashiki K
    Int J Oncol; 1999 Apr; 14(4):709-12. PubMed ID: 10087318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity.
    Wege H; Chui MS; Le HT; Tran JM; Zern MA
    Nucleic Acids Res; 2003 Jan; 31(2):E3-3. PubMed ID: 12527792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine.
    Bracha S; McNamara M; Hilgart I; Milovancev M; Medlock J; Goodall C; Wickramasekara S; Maier CS
    Anal Biochem; 2014 Jun; 455():41-7. PubMed ID: 24704347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of telomerase status on canine osteosarcoma patients.
    Kow K; Thamm DH; Terry J; Grunerud K; Bailey SM; Withrow SJ; Lana SE
    J Vet Intern Med; 2008; 22(6):1366-72. PubMed ID: 18761602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP).
    Jiang S; Tang M; Xin H; Huang J
    Methods Mol Biol; 2017; 1587():95-101. PubMed ID: 28324501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A fluorescent method for detection of telomerase activity.
    Aldous WK; Grabill NR
    Diagn Mol Pathol; 1997 Apr; 6(2):102-10. PubMed ID: 9098649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modified telomeric repeat amplification protocol: a quantitative radioactive assay for telomerase without using electrophoresis.
    Szatmari I; Tókés S; Dunn CB; Bardos TJ; Aradi J
    Anal Biochem; 2000 Jun; 282(1):80-8. PubMed ID: 10860502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using PCR coupled to PAGE for detection and semiquantitative evaluation of telomerase activity.
    Gardano L
    Methods Mol Biol; 2013; 1054():283-93. PubMed ID: 23913300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A PCR-free fluorescence strategy for detecting telomerase activity via double amplification strategy.
    Zhang X; Cheng R; Shi Z; Jin Y
    Biosens Bioelectron; 2016 Jan; 75():101-7. PubMed ID: 26299822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).
    Kim NW; Wu F
    Nucleic Acids Res; 1997 Jul; 25(13):2595-7. PubMed ID: 9185569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.